UK

Usha Kidambi

Active Director Director DIN 11783857
DIN 11783857 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Usha Kidambi

Data last updated:

Usha Kidambi is a Director at Bridge Pharma Infinity Private Limited (since 2026) and Director/Designated Partner at Astravion Pharmaceuticals Llp (since 2026).

DIN 11783857
Primary Designation Director
First Appointment 24 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20262026Active
Director/Designated Partner24 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Astravion Pharmaceuticals Llp
Bridge Pharma Infinity Private Limited
Premium access

Shareholding and investment profile for Usha Kidambi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Kidambi

Usha Kidambi currently holds 2 directorships: Bridge Pharma Infinity Private Limited (Director, since 07 Jul 2026); Astravion Pharmaceuticals Llp (Director/Designated Partner, since 24 Jun 2026).

Usha Kidambi was first appointed on 24 Jun 2026 as Director/Designated Partner at Astravion Pharmaceuticals Llp.

The current boards of Usha Kidambi's companies include Roopa (Bridge Pharma Infinity Private Limited), Bharatesh Kidambi (Bridge Pharma Infinity Private Limited), Medipalli Ambedkar Sastri (Bridge Pharma Infinity Private Limited), Nagaratna Shastrimath (Bridge Pharma Infinity Private Limited), Rashmi Rudragouda Patil (Bridge Pharma Infinity Private Limited), Suma Mallikarjun Hulikantimath (Bridge Pharma Infinity Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available